English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

On March 9, 2010, Richard J. Ablin phd, who was much involved in the discovery of prostate-specific antigen (psa), made national news with his quote, in an Op-Ed piece published in The New York Times1 and a subsequent March 22, 2010, U.S. National Public Radio interview2, that “It’s no better than a coin toss”—describing the psa test’s ability to predict prostate cancer in men. Ablin pointed out that the psa test was never intended to be used for routine screening for prostate cancer in asymptomatic men at low risk and that treatments subsequent to its use left many men not only impotent and incontinent but also with reduced quality of life and varying degrees of psychological problems—all without medical necessity.

current oncology

Prophylactic Bilateral Oophorectomy at Time of Hysterectomy for Women at Low Risk: Acog Revises Practice Guidelines for Ovarian Cancer Screening in Low-Risk Womena